Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. senior Avg
|
New words:
absorption, ADME, animal, ATM, automatically, average, backup, binding, bioavailability, case, challenge, chemotherapy, China, choice, clearance, cyclophilin, death, deemphasize, disability, disappearance, disposition, divided, dual, Ebun, entity, equivalent, eventual, excretion, extension, fit, flow, franchise, furniture, Garner, GDP, glue, good, greater, Guangzhou, higher, Hong, inactive, IND, Joyo, kinetic, Kong, Macau, mainland, Medshine, metabolism, mice, nanomolar, noncash, nonrecurring, Pharmatech, physician, potency, Premium, reassessed, regression, repaid, repriced, repricing, reprioritization, retain, role, service, Shannon, showed, solubility, Sparing, stronger, superior, territory, undiscounted, United, vitro, vivo, voluntarily, weighted, wide, wildtype, window, workforce
Removed:
American, antibody, arm, bispecific, BofA, BRAFTOVI, cancelable, central, declared, directed, domain, Eli, ELS, encouraging, ERBITUX, ERK, Evercore, expansion, Fabre, fee, gastrointestinal, gene, GI, glioma, Guggenheim, inform, international, Life, LifeArc, Lilly, malignant, managing, master, meeting, Morgan, ODD, orphan, partner, Pfizer, Pierre, pivotal, poster, protocol, Pte, registration, Stanley, ULK, user
Filing tables
Filing exhibits
Related press release
ERAS similar filings
Filing view
External links